109 results
Page 2 of 6
424B5
p06f19
27 Jul 23
Prospectus supplement for primary offering
5:28pm
8-K
EX-99.1
5g3sz8fk
26 Jul 23
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
7:42am
8-K
8jpco
26 Jul 23
Inozyme Pharma Announces Updates on Global Development Strategy of INZ-701 for the Treatment of ENPP1 Deficiency
7:42am
8-K
EX-99.1
m1xx yrgyzpfgw3j0
9 May 23
Inozyme Pharma Reports First Quarter 2023 Financial Results and Provides Business Highlights
8:35am
8-K
EX-10.2
d81rp2 606r2
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-10.1
0uiq5y0u6gxl0jsglrat
8 Dec 22
Departure of Directors or Certain Officers
4:14pm
8-K
EX-99.1
5r6p6ko
10 Nov 22
Inozyme Pharma Reports Third Quarter 2022 Financial Results and Provides Business Updates
8:35am
8-K
EX-99.1
5bf85v0i
15 Aug 22
Inozyme Pharma Reports Second Quarter 2022 Financial Results and Provides Business Updates
7:36am
8-K
jlnvryc4
19 Jul 22
Regulation FD Disclosure
4:36pm
8-K
EX-99.1
qdkffq6 nc2zqie
19 Jul 22
Regulation FD Disclosure
4:36pm